Substance

ID:288

Dexbrompheniramine

Names and Identifiers
Synonyms
ParabromdylamineParabromodylamineDexbrompheniramineD-Brompheniramine
IUPAC name
[(3S)-3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
IUPAC Traditional name
dexbrompheniramine
Brand Name
Ilvin
Registration numbers
PubChem CID
PubChem SID
CAS Number
Properties
Physical Property
Hydrophobicity(logP)
3.4
Molecule Details
Drug Groups
approved
Description
Dexbrompheniramine maleate is an antihistamine used to treat allergic conditions such as hay fever or urticaria.
Indication
For treatment and relief of symptoms of allergies, hay fever, and colds
Pharmacology
In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Dexbrompheniramine is a histamine H1 antagonist (or more correctly, an inverse histamine agonist) of the alkylamine class. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
Toxicity
Signs of an overdose include fast or irregular heartbeat, mental or mood changes, tightness in the chest, and unusual tiredness or weakness.
Affected Organisms
Humans and other mammals
Biotransformation
Hepatic (cytochrome P-450 system), some renal.
Absorption
Antihistamines are well absorbed from the gastrointestinal tract after oral administration.
Half Life
25 hours
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data